

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb10342</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Fayez</surname><given-names>Diman</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Saliminejad</surname><given-names>Kioomars</given-names></name></contrib><aff>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Irani</surname><given-names>Shiva</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Kamali</surname><given-names>Koorosh</given-names></name></contrib><aff>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR      , Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Memariani</surname><given-names>Toktam</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Khorram Khorshid</surname><given-names>Hamid Reza</given-names></name></contrib><aff>Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran      , Tehran, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>10</volume>
      <issue>3</issue>
      <fpage>163</fpage>
      <lpage>167</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>6</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>10</month>
          <year>2017</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Human arylamine N-acetyltransferase 2 (&lt;em&gt;NAT2&lt;/em&gt;) gene has a key role in xenobiotic metabolism through the conjugation of acetyl group to xenobiotic substances. &lt;em&gt;NAT2&lt;/em&gt; has been suggested as a susceptibility factor in endometriosis; however, the results of studies have been controversial. In this study, the association of &lt;em&gt;NAT2&lt;/em&gt; polymorphisms with susceptibility to endometriosis was evaluated in an Iranian population.&amp;nbsp;&lt;br /&gt;
Methods: This is an association study and totally 141 women with diagnosis of endometriosis and 158 healthy women as control group were analyzed for &lt;em&gt;NAT2&lt;/em&gt; gene polymorphisms (C481T, A803G, G857A and G590A) by PCR-RFLP methods.&lt;br /&gt;
Results: The 590 GA genotype was significantly lower (p=0.001; OR=0.42, 95% CI: 0.25-0.71) in the patients (38.3%) than the control group (55.1%). The 590A allele was significantly lower (p=0.033; OR=0.69, 95% CI: 0.49-0.79) in the patients (31.2%) compared with the controls (39.6%). Analysis of haplotypes showed that NAT2 481C, 803A, 590A, 587A combination was significantly different between the case and control women (p= 0.029; OR=3.11, 95% CI: 1.13-8.52).&lt;br /&gt;
Conclusion: The &lt;em&gt;NAT2&lt;/em&gt; G590A SNP may be associated with susceptibility to endometriosis and the 590A allele may have a protective role in development of endometriosis. The &lt;em&gt;NAT2&lt;/em&gt; 481C, 803A, 590A, 587A haplotype was associated with a higher risk of endometriosis in Iranian population.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
